抗生素
抗药性
抗生素耐药性
多重耐药
重症监护医学
药品
抗性(生态学)
生物
生物技术
风险分析(工程)
医学
药理学
微生物学
生态学
作者
Michael Baym,Laura K. Stone,Roy Kishony
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2015-12-31
卷期号:351 (6268): aad3292-aad3292
被引量:726
标识
DOI:10.1126/science.aad3292
摘要
Antibiotic treatment has two conflicting effects: the desired, immediate effect of inhibiting bacterial growth and the undesired, long-term effect of promoting the evolution of resistance. Although these contrasting outcomes seem inextricably linked, recent work has revealed several ways by which antibiotics can be combined to inhibit bacterial growth while, counterintuitively, selecting against resistant mutants. Decoupling treatment efficacy from the risk of resistance can be achieved by exploiting specific interactions between drugs, and the ways in which resistance mutations to a given drug can modulate these interactions or increase the sensitivity of the bacteria to other compounds. Although their practical application requires much further development and validation, and relies on advances in genomic diagnostics, these discoveries suggest novel paradigms that may restrict or even reverse the evolution of resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI